© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
May 11th 2021, 9:00pm
The Geron Corporation announced that the first patient has been dosed with GRN163L — an experimental agent — in a phase 3 clinical trial to assess the drug’s overall survival benefit compared to best available therapy in patients with refractory myelofibrosis.
May 11th 2021, 1:00pm
Treatment with daily Jakafi and parsaclisib improved spleen volume reduction and symptom burden in patients with myelofibrosis who had previously failed to achieve significant response to single-agent Jakafi.
April 14th 2021, 1:00pm
Reintroducing treatment with Jakafi in patients with myelofibrosis after previous discontinuation extended overall survival compared to those patients who stopped permanently, although there was a substantial rate of permanent treatment discontinuation with this therapy.
April 2nd 2021, 6:00pm
At four-year follow up, treatment with givinostat, a histone-deacetylase inhibitor, continued to be safe and effective with no serious or life-threatening side effects.
March 17th 2021, 9:00pm
Of note, estimates show that there are more than 25,000 patients undergoing allogeneic hematopoietic cell transplantations throughout the United States and beyond. Recent study results show that these patients may be at a higher risk for de novo atrial fibrillation.
December 18th 2020, 12:00am
Watch our Myeloproliferative Neoplasms Webinar where an expert panel discussed topics highly relevant to patients, caregivers and advocates right now.
December 6th 2020, 6:23pm
In an interview with CURE®, lead study investigator Dr. John Mascarenhas discusses what the results of the phase 2 IMbark study could mean for the future of patients with myelofibrosis.
December 5th 2020, 8:00pm
An analysis of the phase 2 study IMbark shows how imetelstat can offer patients with high-risk myelofibrosis multiple clinical benefits, setting the stage for an expanded phase 3 trial.
December 5th 2020, 3:00pm
Five patient advocates, two oncologists and one caregiver were honored during CURE®’s eighth annual MPN Heroes Program.
December 5th 2020, 12:00am
Watch the entire MPN Heroes program here!
An Oncology Nurse Wears Many Hats
Inaccurate Information on Cancer Diagnosis and Treatment Common on Social Media Sites
Small-Town Cancer Team, Big Success
Grief Is Like Swimming